Laura Prendergast
Stock Analyst at Stifel Nicolaus
(4.84)
# 393
Out of 4,581 analysts
71
Total ratings
69%
Success rate
50.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintained: Buy | $215 | $183.86 | +16.94% | 19 | Jul 23, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $45 | $40.67 | +10.65% | 9 | Jun 15, 2026 | |
| ORIC ORIC Pharmaceuticals | Initiated Coverage: Buy | $14 | $11.91 | +17.55% | 1 | Jun 12, 2026 | |
| FHTX Foghorn Therapeutics | Maintained: Buy | $12 | $5.13 | +133.92% | 6 | Jun 1, 2026 | |
| ERAS Erasca | Maintained: Buy | $30 | $18.16 | +65.20% | 11 | Jun 1, 2026 | |
| TNGX Tango Therapeutics | Maintained: Buy | $40 | $26.65 | +50.09% | 9 | May 25, 2026 | |
| BDTX Black Diamond Therapeutics | Maintained: Buy | $8 | $1.76 | +354.55% | 6 | May 22, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $23 | $8.59 | +167.75% | 4 | May 13, 2026 | |
| OLMA Olema Pharmaceuticals | Initiated Coverage: Buy | $48 | $11.62 | +313.08% | 1 | Feb 11, 2026 | |
| HLIT Harmonic | Maintained: Buy | $12 | $11.06 | n/a | 3 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $9.15 | n/a | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 | $2.22 | n/a | 1 | Aug 14, 2024 |
Revolution Medicines
Jul 23, 2026
Maintained: Buy
Price Target: $215
Current: $183.86
Upside: +16.94%
Cogent Biosciences
Jun 15, 2026
Maintained: Buy
Price Target: $45
Current: $40.67
Upside: +10.65%
ORIC Pharmaceuticals
Jun 12, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $11.91
Upside: +17.55%
Foghorn Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $12
Current: $5.13
Upside: +133.92%
Erasca
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $18.16
Upside: +65.20%
Tango Therapeutics
May 25, 2026
Maintained: Buy
Price Target: $40
Current: $26.65
Upside: +50.09%
Black Diamond Therapeutics
May 22, 2026
Maintained: Buy
Price Target: $8
Current: $1.76
Upside: +354.55%
BridgeBio Oncology Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $23
Current: $8.59
Upside: +167.75%
Olema Pharmaceuticals
Feb 11, 2026
Initiated Coverage: Buy
Price Target: $48
Current: $11.62
Upside: +313.08%
Harmonic
Jul 29, 2025
Maintained: Buy
Price Target: $12
Current: $11.06
Upside: n/a
Feb 13, 2025
Maintained: Buy
Price Target: $4
Current: $9.15
Upside: n/a
Aug 14, 2024
Upgraded: Buy
Price Target: $16
Current: $2.22
Upside: n/a